TY - JOUR
T1 - Radiation therapy for idiopathic orbital myositis
T2 - Two case reports and literature review
AU - Isobe, Koichi
AU - Uno, Takashi
AU - Kawakami, Hiroyuki
AU - Ueno, Naoyuki
AU - Kawata, Tetsuya
AU - Abe, Hideki
AU - Minowa, Katsuyuki
AU - Yamamoto, Shuichi
AU - Ito, Hisao
PY - 2004/11
Y1 - 2004/11
N2 - We report two cases of idiopathic orbital myositis treated with radiation therapy (RT). Both patients visited our hospital with complaints of orbital pain on eye movement and eyelid swelling. There was no history of thyroid disease or trauma, and no signs of infection, neoplasm, or collagen disease. The laboratory investigations, including a thyroid function test, showed no abnormalities in either woman. They were initially treated with a combination of corticosteroids (CS) and nonsteroidal anti-inflammatory drugs (NSAIDs), however, they became dependent on or refractory to oral CS therapy, and received 20 Gy in 10 fractions of RT to the orbit. Their symptoms decreased immediately, and both patients were able to reduce the dosage of oral CS after RT. One patient could completely withdraw oral CS thereafter. However, they both experienced recurrence at eight months after RT, and have been receiving oral CS to control their symptoms. RT at doses of 20 Gy in 10 fractions for patients with idiopathic orbital myositis appears to be effective in palliating symptoms, but long-term control is not satisfactory.
AB - We report two cases of idiopathic orbital myositis treated with radiation therapy (RT). Both patients visited our hospital with complaints of orbital pain on eye movement and eyelid swelling. There was no history of thyroid disease or trauma, and no signs of infection, neoplasm, or collagen disease. The laboratory investigations, including a thyroid function test, showed no abnormalities in either woman. They were initially treated with a combination of corticosteroids (CS) and nonsteroidal anti-inflammatory drugs (NSAIDs), however, they became dependent on or refractory to oral CS therapy, and received 20 Gy in 10 fractions of RT to the orbit. Their symptoms decreased immediately, and both patients were able to reduce the dosage of oral CS after RT. One patient could completely withdraw oral CS thereafter. However, they both experienced recurrence at eight months after RT, and have been receiving oral CS to control their symptoms. RT at doses of 20 Gy in 10 fractions for patients with idiopathic orbital myositis appears to be effective in palliating symptoms, but long-term control is not satisfactory.
KW - Idiopathic orbital myositis
KW - Radiation therapy
KW - Steroid
UR - http://www.scopus.com/inward/record.url?scp=12444265797&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=12444265797&partnerID=8YFLogxK
M3 - Review article
C2 - 15648461
AN - SCOPUS:12444265797
SN - 0288-2043
VL - 22
SP - 429
EP - 431
JO - Radiation Medicine - Medical Imaging and Radiation Oncology
JF - Radiation Medicine - Medical Imaging and Radiation Oncology
IS - 6
ER -